Citigroup
RPID icon

Citigroup’s Rapid Micro Biosystems RPID Stock Holding History

Citigroup’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,832
Closed -$14K – 6327
2025
Q4 		$14K Buy
4,832
+4,831
+483,100% +$16.8K ﹤0.01% 4962
2025
Q3 		$3 Buy
+1
New +$3 ﹤0.01% 6008
2023
Q2 		– Sell
-15,661
Closed -$20.5K – 5696
2023
Q1 		$20.5K Buy
15,661
+15,523
+11,249% +$20.2K ﹤0.01% 4505
2022
Q4 		$156 Sell
138
-418
-75% -$1.01K ﹤0.01% 5614
2022
Q3 		$2K Sell
556
-8,869
-94% -$34.4K ﹤0.01% 5527
2022
Q2 		$41K Buy
9,425
+8,085
+603% +$37.6K ﹤0.01% 4624
2022
Q1 		$9K Sell
1,340
-1,896
-59% -$14K ﹤0.01% 5587
2021
Q4 		$34K Buy
3,236
+2,323
+254% +$36.3K ﹤0.01% 5234
2021
Q3 		$17K Buy
+913
New +$18.9K ﹤0.01% 5299

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
EFA
Evernest Financial Advisors Carmel, Indiana $481M AUM 19.97% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's RPID Position: Q1 2026 in Review

Citigroup sold out of Rapid Micro Biosystems (RPID) in Q1 2026, closing a stake of 4,832 shares — an estimated $14K sold.

Citigroup first reported a position in RPID in Q3 2021 and held it in 9 quarters. The position peaked at $41K in Q2 2022. 46 funds tracked by Wall St. Rank hold RPID as of Q1 2026.

  • Citigroup reported no remaining Rapid Micro Biosystems position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 4,832 Rapid Micro Biosystems shares in Q1 2026, an estimated $14K.
  • Citigroup first reported a position in Rapid Micro Biosystems in Q3 2021 and held it in 9 quarters.
  • Citigroup's Rapid Micro Biosystems position peaked at $41K in Q2 2022.
  • 46 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.